Jean F. Voltaire

Array ( [id] => 4442555 [patent_doc_number] => 07928138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Marine actinomycete taxon for drug and fermentation product discovery' [patent_app_type] => utility [patent_app_number] => 11/966787 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6732 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928138.pdf [firstpage_image] =>[orig_patent_app_number] => 11966787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527860 [patent_doc_number] => 20090197937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'MARINE ACTINOMYCETE TAXON FOR DRUG AND FERMENTATION PRODUCT DISCOVERY' [patent_app_type] => utility [patent_app_number] => 11/966801 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6445 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197937.pdf [firstpage_image] =>[orig_patent_app_number] => 11966801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4575203 [patent_doc_number] => 07825127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Method for treating cancer' [patent_app_type] => utility [patent_app_number] => 12/005883 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38695 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825127.pdf [firstpage_image] =>[orig_patent_app_number] => 12005883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6322032 [patent_doc_number] => 20100113590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'ADAM INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/524543 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7130 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113590.pdf [firstpage_image] =>[orig_patent_app_number] => 12524543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740645 [patent_doc_number] => 20080234298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'ANTIFOLATE AGENT COMBINATIONS IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/963644 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18333 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234298.pdf [firstpage_image] =>[orig_patent_app_number] => 11963644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001364 [patent_doc_number] => 09045442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Antibacterial compounds and methods of using same' [patent_app_type] => utility [patent_app_number] => 12/680541 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 17282 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490890 [patent_doc_number] => 20090291961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'COMBINATION OF AN MEK INHIBITOR AND THE SRC KINASE INHIBITOR AZD0530 FOR USE IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/520639 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6608 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291961.pdf [firstpage_image] =>[orig_patent_app_number] => 12520639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664180 [patent_doc_number] => 20080255087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/956841 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22389 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255087.pdf [firstpage_image] =>[orig_patent_app_number] => 11956841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926996 [patent_doc_number] => 20080166359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Methods of using MEK inhibitors' [patent_app_type] => utility [patent_app_number] => 12/002340 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 160449 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166359.pdf [firstpage_image] =>[orig_patent_app_number] => 12002340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11236564 [patent_doc_number] => 09463195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Dissolution of amyloid fibrils by flavonoids and other compounds' [patent_app_type] => utility [patent_app_number] => 12/519058 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 24 [patent_no_of_words] => 8346 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728034 [patent_doc_number] => 20080207578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'METHOD OF INDUCING APOPTOSIS IN CANCER TREATMENT BY USING CUCURBITACINS' [patent_app_type] => utility [patent_app_number] => 11/954805 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6968 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207578.pdf [firstpage_image] =>[orig_patent_app_number] => 11954805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424335 [patent_doc_number] => 20100168064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'NOVEL HYDROPHILIC DERIVATIVES OF 2-ARYL-4-QUINOLONES AS ANTICANCER AGENTS' [patent_app_type] => utility [patent_app_number] => 12/448088 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11389 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168064.pdf [firstpage_image] =>[orig_patent_app_number] => 12448088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867594 [patent_doc_number] => 20080146653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'SYNERGISTIC ANTI-CANCER COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/951638 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18046 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146653.pdf [firstpage_image] =>[orig_patent_app_number] => 11951638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880508 [patent_doc_number] => 20080153891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'SYNERGISTIC ANTI-CANCER COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/951604 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18049 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153891.pdf [firstpage_image] =>[orig_patent_app_number] => 11951604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899928 [patent_doc_number] => 20080119542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'METHODS OF USING ARTEMISININ-LIKE COMPOUNDS TO PREVENT OR DELAY THE APPEARANCE OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/948560 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4757 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119542.pdf [firstpage_image] =>[orig_patent_app_number] => 11948560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718752 [patent_doc_number] => 20080241274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Indibulin therapy' [patent_app_type] => utility [patent_app_number] => 11/986844 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12264 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241274.pdf [firstpage_image] =>[orig_patent_app_number] => 11986844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446988 [patent_doc_number] => 20090048214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds' [patent_app_type] => utility [patent_app_number] => 11/940930 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14608 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048214.pdf [firstpage_image] =>[orig_patent_app_number] => 11940930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870770 [patent_doc_number] => 08466147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Use of reversine and analogs for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/514360 [patent_app_country] => US [patent_app_date] => 2007-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11301 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12514360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307235 [patent_doc_number] => 20100069411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'CANCER TREATMENT METHOD' [patent_app_type] => utility [patent_app_number] => 12/516661 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6985 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069411.pdf [firstpage_image] =>[orig_patent_app_number] => 12516661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720125 [patent_doc_number] => 20080242648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'COMBINATION OF ERa+ LIGANDS AND HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/938130 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32550 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242648.pdf [firstpage_image] =>[orig_patent_app_number] => 11938130 [rel_patent_id] =>[rel_patent_doc_number] =>)